Cargando…
Pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: the new kid on the block
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512467/ https://www.ncbi.nlm.nih.gov/pubmed/34733633 http://dx.doi.org/10.21037/tlcr-20-715 |
| _version_ | 1784582998087172096 |
|---|---|
| author | Hockenhull, Kimberley Ortega-Franco, Ana Califano, Raffaele |
| author_facet | Hockenhull, Kimberley Ortega-Franco, Ana Califano, Raffaele |
| author_sort | Hockenhull, Kimberley |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8512467 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85124672021-11-02 Pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: the new kid on the block Hockenhull, Kimberley Ortega-Franco, Ana Califano, Raffaele Transl Lung Cancer Res Editorial Commentary AME Publishing Company 2021-09 /pmc/articles/PMC8512467/ /pubmed/34733633 http://dx.doi.org/10.21037/tlcr-20-715 Text en 2021 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Hockenhull, Kimberley Ortega-Franco, Ana Califano, Raffaele Pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: the new kid on the block |
| title | Pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: the new kid on the block |
| title_full | Pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: the new kid on the block |
| title_fullStr | Pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: the new kid on the block |
| title_full_unstemmed | Pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: the new kid on the block |
| title_short | Pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: the new kid on the block |
| title_sort | pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: the new kid on the block |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512467/ https://www.ncbi.nlm.nih.gov/pubmed/34733633 http://dx.doi.org/10.21037/tlcr-20-715 |
| work_keys_str_mv | AT hockenhullkimberley pembrolizumabplusplatinumbasedchemotherapyforsquamousnonsmallcelllungcancerthenewkidontheblock AT ortegafrancoana pembrolizumabplusplatinumbasedchemotherapyforsquamousnonsmallcelllungcancerthenewkidontheblock AT califanoraffaele pembrolizumabplusplatinumbasedchemotherapyforsquamousnonsmallcelllungcancerthenewkidontheblock |